Journal of Advanced Research-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2231113, encodeId=b6862231113df, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啊我的技术审查两天就结束了，结束了之后会发邮件。告诉我结束了，然后过了两天又发邮件告诉我稿件进入杂志社with editor了没有大家说的这么慢啊？额。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d926582636, createdName=ms6000000720735535, createdTime=Tue Oct 15 23:13:27 CST 2024, time=2024-10-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150376, encodeId=6c1e21503e6da, content=偏重的研究方向：医学 经验分享：under review中。请问各位是否WB都需要提供3份？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=伊丽莎白酱, createdTime=Sat Jul 29 14:49:45 CST 2023, time=2023-07-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157727, encodeId=0abf215e7279c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：格式审查很严格，审稿人很专业，提出了很多问题，两次大修后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4945416220, createdName=ms7000001102062575, createdTime=Thu Sep 14 20:25:53 CST 2023, time=2023-09-14, status=1, ipAttribution=河北省)]

2022-01-18 ms3000001224934147

求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？

143 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2231113, encodeId=b6862231113df, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啊我的技术审查两天就结束了，结束了之后会发邮件。告诉我结束了，然后过了两天又发邮件告诉我稿件进入杂志社with editor了没有大家说的这么慢啊？额。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d926582636, createdName=ms6000000720735535, createdTime=Tue Oct 15 23:13:27 CST 2024, time=2024-10-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150376, encodeId=6c1e21503e6da, content=偏重的研究方向：医学 经验分享：under review中。请问各位是否WB都需要提供3份？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=伊丽莎白酱, createdTime=Sat Jul 29 14:49:45 CST 2023, time=2023-07-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157727, encodeId=0abf215e7279c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：格式审查很严格，审稿人很专业，提出了很多问题，两次大修后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4945416220, createdName=ms7000001102062575, createdTime=Thu Sep 14 20:25:53 CST 2023, time=2023-09-14, status=1, ipAttribution=河北省)]

2024-11-28 ms4000000276779176 来自上海

偏重的研究方向：医学
经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了

7 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2231113, encodeId=b6862231113df, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啊我的技术审查两天就结束了，结束了之后会发邮件。告诉我结束了，然后过了两天又发邮件告诉我稿件进入杂志社with editor了没有大家说的这么慢啊？额。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d926582636, createdName=ms6000000720735535, createdTime=Tue Oct 15 23:13:27 CST 2024, time=2024-10-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150376, encodeId=6c1e21503e6da, content=偏重的研究方向：医学 经验分享：under review中。请问各位是否WB都需要提供3份？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=伊丽莎白酱, createdTime=Sat Jul 29 14:49:45 CST 2023, time=2023-07-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157727, encodeId=0abf215e7279c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：格式审查很严格，审稿人很专业，提出了很多问题，两次大修后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4945416220, createdName=ms7000001102062575, createdTime=Thu Sep 14 20:25:53 CST 2023, time=2023-09-14, status=1, ipAttribution=河北省)]

2024-11-18 ms6000001210637983 来自加利福尼亚

我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊

19 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2231113, encodeId=b6862231113df, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啊我的技术审查两天就结束了，结束了之后会发邮件。告诉我结束了，然后过了两天又发邮件告诉我稿件进入杂志社with editor了没有大家说的这么慢啊？额。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d926582636, createdName=ms6000000720735535, createdTime=Tue Oct 15 23:13:27 CST 2024, time=2024-10-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150376, encodeId=6c1e21503e6da, content=偏重的研究方向：医学 经验分享：under review中。请问各位是否WB都需要提供3份？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=伊丽莎白酱, createdTime=Sat Jul 29 14:49:45 CST 2023, time=2023-07-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157727, encodeId=0abf215e7279c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：格式审查很严格，审稿人很专业，提出了很多问题，两次大修后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4945416220, createdName=ms7000001102062575, createdTime=Thu Sep 14 20:25:53 CST 2023, time=2023-09-14, status=1, ipAttribution=河北省)]

2024-12-09 ms9000000123620406 来自陕西省

偏重的研究方向：农林科学;食品毒理
经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要

12 0

[GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2231113, encodeId=b6862231113df, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啊我的技术审查两天就结束了，结束了之后会发邮件。告诉我结束了，然后过了两天又发邮件告诉我稿件进入杂志社with editor了没有大家说的这么慢啊？额。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d926582636, createdName=ms6000000720735535, createdTime=Tue Oct 15 23:13:27 CST 2024, time=2024-10-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150376, encodeId=6c1e21503e6da, content=偏重的研究方向：医学 经验分享：under review中。请问各位是否WB都需要提供3份？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=伊丽莎白酱, createdTime=Sat Jul 29 14:49:45 CST 2023, time=2023-07-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157727, encodeId=0abf215e7279c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：格式审查很严格，审稿人很专业，提出了很多问题，两次大修后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4945416220, createdName=ms7000001102062575, createdTime=Thu Sep 14 20:25:53 CST 2023, time=2023-09-14, status=1, ipAttribution=河北省)]

2024-11-26 ms4000001186611146 来自山东省

大家Pending Technical Assessment这个状态持续多久啊？

12 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2231113, encodeId=b6862231113df, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啊我的技术审查两天就结束了，结束了之后会发邮件。告诉我结束了，然后过了两天又发邮件告诉我稿件进入杂志社with editor了没有大家说的这么慢啊？额。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d926582636, createdName=ms6000000720735535, createdTime=Tue Oct 15 23:13:27 CST 2024, time=2024-10-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150376, encodeId=6c1e21503e6da, content=偏重的研究方向：医学 经验分享：under review中。请问各位是否WB都需要提供3份？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=伊丽莎白酱, createdTime=Sat Jul 29 14:49:45 CST 2023, time=2023-07-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157727, encodeId=0abf215e7279c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：格式审查很严格，审稿人很专业，提出了很多问题，两次大修后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4945416220, createdName=ms7000001102062575, createdTime=Thu Sep 14 20:25:53 CST 2023, time=2023-09-14, status=1, ipAttribution=河北省)]

2024-11-22 第五先生来自江苏省

偏重的研究方向：肿瘤;代谢;药学
经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦

17 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2231113, encodeId=b6862231113df, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啊我的技术审查两天就结束了，结束了之后会发邮件。告诉我结束了，然后过了两天又发邮件告诉我稿件进入杂志社with editor了没有大家说的这么慢啊？额。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d926582636, createdName=ms6000000720735535, createdTime=Tue Oct 15 23:13:27 CST 2024, time=2024-10-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150376, encodeId=6c1e21503e6da, content=偏重的研究方向：医学 经验分享：under review中。请问各位是否WB都需要提供3份？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=伊丽莎白酱, createdTime=Sat Jul 29 14:49:45 CST 2023, time=2023-07-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157727, encodeId=0abf215e7279c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：格式审查很严格，审稿人很专业，提出了很多问题，两次大修后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4945416220, createdName=ms7000001102062575, createdTime=Thu Sep 14 20:25:53 CST 2023, time=2023-09-14, status=1, ipAttribution=河北省)]

2024-10-15 ms6000000720735535 来自江苏省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：啊我的技术审查两天就结束了，结束了之后会发邮件。告诉我结束了，然后过了两天又发邮件告诉我稿件进入杂志社with editor了没有大家说的这么慢啊？额。。

31 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2231113, encodeId=b6862231113df, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啊我的技术审查两天就结束了，结束了之后会发邮件。告诉我结束了，然后过了两天又发邮件告诉我稿件进入杂志社with editor了没有大家说的这么慢啊？额。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d926582636, createdName=ms6000000720735535, createdTime=Tue Oct 15 23:13:27 CST 2024, time=2024-10-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150376, encodeId=6c1e21503e6da, content=偏重的研究方向：医学 经验分享：under review中。请问各位是否WB都需要提供3份？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=伊丽莎白酱, createdTime=Sat Jul 29 14:49:45 CST 2023, time=2023-07-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157727, encodeId=0abf215e7279c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：格式审查很严格，审稿人很专业，提出了很多问题，两次大修后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4945416220, createdName=ms7000001102062575, createdTime=Thu Sep 14 20:25:53 CST 2023, time=2023-09-14, status=1, ipAttribution=河北省)]

2024-04-10 ms2000000076814193 来自浙江省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：细胞生物学;急危重病
经验分享：2024.2.2投稿
技术审查10天
with editor 3天
2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天）
2024.3.26修回
2024.4.7接收

感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。

93 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2231113, encodeId=b6862231113df, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啊我的技术审查两天就结束了，结束了之后会发邮件。告诉我结束了，然后过了两天又发邮件告诉我稿件进入杂志社with editor了没有大家说的这么慢啊？额。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d926582636, createdName=ms6000000720735535, createdTime=Tue Oct 15 23:13:27 CST 2024, time=2024-10-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150376, encodeId=6c1e21503e6da, content=偏重的研究方向：医学 经验分享：under review中。请问各位是否WB都需要提供3份？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=伊丽莎白酱, createdTime=Sat Jul 29 14:49:45 CST 2023, time=2023-07-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157727, encodeId=0abf215e7279c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：格式审查很严格，审稿人很专业，提出了很多问题，两次大修后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4945416220, createdName=ms7000001102062575, createdTime=Thu Sep 14 20:25:53 CST 2023, time=2023-09-14, status=1, ipAttribution=河北省)]

2023-07-29 伊丽莎白酱来自广西

偏重的研究方向：医学
经验分享：under review中。请问各位是否WB都需要提供3份？

108 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2231113, encodeId=b6862231113df, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啊我的技术审查两天就结束了，结束了之后会发邮件。告诉我结束了，然后过了两天又发邮件告诉我稿件进入杂志社with editor了没有大家说的这么慢啊？额。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d926582636, createdName=ms6000000720735535, createdTime=Tue Oct 15 23:13:27 CST 2024, time=2024-10-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150376, encodeId=6c1e21503e6da, content=偏重的研究方向：医学 经验分享：under review中。请问各位是否WB都需要提供3份？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a195415790, createdName=伊丽莎白酱, createdTime=Sat Jul 29 14:49:45 CST 2023, time=2023-07-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157727, encodeId=0abf215e7279c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：格式审查很严格，审稿人很专业，提出了很多问题，两次大修后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4945416220, createdName=ms7000001102062575, createdTime=Thu Sep 14 20:25:53 CST 2023, time=2023-09-14, status=1, ipAttribution=河北省)]

2023-09-14 ms7000001102062575 来自河北省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：微生物
经验分享：格式审查很严格，审稿人很专业，提出了很多问题，两次大修后接收

94 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务